BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15059132)

  • 1. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
    Ljungman P
    Br J Haematol; 2004 Apr; 125(2):107-16. PubMed ID: 15059132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytomegalovirus and blood transfusion].
    Eggen BM
    Tidsskr Nor Laegeforen; 1993 Jan; 113(1):22-4. PubMed ID: 8380944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-transmitted cytomegalovirus: lessons from a murine model.
    Roback JD; Su L; Zimring JC; Hillyer CD
    Transfus Med Rev; 2007 Jan; 21(1):26-36. PubMed ID: 17174218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in transfusion therapy.
    Beck SJ
    Clin Lab Sci; 1994; 7(4):225-31. PubMed ID: 10147432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M; Heim MU
    Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    Reesink HW; Engelfriet CP; Tegtmeier GE; O'Riordan J; Eglin R; Barbara JA; Flanagan P; Lin CK; Rawlinson W; Muylle L; Wendel S; Biagini S; Lazar AE; Krusius T; Alitupa E; Grillner L; Preiser W; Doerr HW; Brand A; Zupanska B; Brojer E; Degré M
    Vox Sang; 2002 Jul; 83(1):72-87. PubMed ID: 12100393
    [No Abstract]   [Full Text] [Related]  

  • 8. Indications for the use of cytomegalovirus-seronegative blood products.
    Preiksaitis JK
    Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical benefits of the leukoreduction of blood products.
    Blajchman MA
    J Trauma; 2006 Jun; 60(6 Suppl):S83-90. PubMed ID: 16763486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cytomegalovirus infection by using leukocyte-depleted components.
    Sayers M
    Curr Stud Hematol Blood Transfus; 1994; (60):41-52. PubMed ID: 8088169
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of leukocyte depletion in the prevention of transfusion-induced cytomegalovirus infection.
    Andreu G
    Semin Hematol; 1991 Jul; 28(3 Suppl 5):26-31. PubMed ID: 1656529
    [No Abstract]   [Full Text] [Related]  

  • 12. [The eclectic cellular tropism of cytomegalovirus].
    Landini MP; Jahn G
    Pathologica; 2000 Apr; 92(2):51-7. PubMed ID: 10838868
    [No Abstract]   [Full Text] [Related]  

  • 13. The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?
    Preiksaitis JK
    Transfus Med Rev; 2000 Apr; 14(2):112-36. PubMed ID: 10782497
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights for preventing transfusion-transmitted cytomegalovirus and other white blood cell-associated viral infections.
    Roback JD; Josephson CD
    Transfusion; 2013 Oct; 53(10):2112-6. PubMed ID: 24099337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transmission of viral infections during transfusion of blood and its components].
    Agranenko VA; Krizhevskaia IuV
    Gematol Transfuziol; 1991 Jun; 36(6):25-7. PubMed ID: 1663054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new Light Diagnostics and the CMV Brite to an in-house developed human cytomegalovirus antigenemia assay.
    Percivalle E; Genini E; Chiesa A; Gerna G
    J Clin Virol; 2008 Sep; 43(1):13-7. PubMed ID: 18468948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion support in liver transplantation.
    Triulzi DJ
    Curr Hematol Rep; 2004 Nov; 3(6):444-9. PubMed ID: 15496279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus and other herpes viruses.
    Lang DJ; Drew WL
    Transfus Med Rev; 1988 Dec; 2(4):294-5. PubMed ID: 2856532
    [No Abstract]   [Full Text] [Related]  

  • 20. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
    Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.